• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number 82090-01
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Paresis (1998); Nervous System Injury (2689); Thrombosis/Thrombus (4440)
Date of Event 01/20/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents reported from this lot.The reported patient effects of neurological complications and thrombosis are listed in the xact instructions for use as known potential patient effects potentially associated with carotid stents and embolic protection systems.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The additional non-surgical treatment (unexpected medical intervention) and medication was related to operational context.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event or Problem Description
It was reported that the procedure was performed to treat a lesion in the common carotid artery.An 8x40mm xact self-expanding stent system (sess) was used without issue.One hour after the procedure, the patient developed hemiparesis of the right limb, slurred speech, and thrombosis.Suction, thrombectomy, and thrombolysis were performed.Angiography confirmed that the thrombus in the stent was completely cleared and the blood flow in the stent was normal.Additionally, the hemiparesis and slurred speech were resolved.There were no adverse patient sequelae and no clinically significant delay in the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XACT CAROTID STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11649290
Report Number2024168-2021-03004
Device Sequence Number3367380
Product Code NIM
UDI-Device Identifier08717648010262
UDI-Public08717648010262
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P040038
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2023
Device Model Number82090-01
Device Catalogue Number82090-01
Device Lot Number0081861
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/23/2021
Initial Report FDA Received Date04/12/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-